Latest news
Praxis Precision Medicines Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 08:04:00 GMTPraxis Precision Medicines, Inc. Stock 12‑Month Price Target Raised to $620.95, Implies 95% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:28 GMTPraxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:07:54 GMTPraxis Precision Medicines Q2 2026: Net loss $(83.7M), EPS $(2.87) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:41:00 GMT